Apolipoprotein B Familial Hypobetalipoproteinemia
An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.
Also Known As:
Hypobetalipoproteinemia, Familial, Apolipoprotein B; Abetalipoproteinemia, Normotriglyceridemic, Steinbert Type; Apolipoprotein B Deficiency Disease; Hypobetalipoproteinemia, Familial, Apo B; Apolipoprotein B Deficiencies; Apolipoprotein B Deficiency
Networked: 7
relevant articles (0 outcomes,
0 trials/studies)
Disease Context: Research Results
Related Diseases
Experts
1. | Desai, H G:
2 articles
(01/2003 - 02/2001)
|
2. | Albrecht, C:
1 article
(04/2016)
|
3. | Bruckmaier, R M:
1 article
(04/2016)
|
4. | Drögemüller, C:
1 article
(04/2016)
|
5. | Gross, J J:
1 article
(04/2016)
|
6. | Menzi, F:
1 article
(04/2016)
|
7. | Schmitz-Hsu, F:
1 article
(04/2016)
|
8. | Schwinn, A-C:
1 article
(04/2016)
|
9. | Artekar, T M:
1 article
(01/2003)
|
10. | Shah, S S:
1 article
(02/2001)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Apolipoprotein B Familial Hypobetalipoproteinemia: